openPR Logo
Press release

Rare Neurological Disease Treatment Market 2021 Demands to Boost Industry Growth and Revenue Post Covid-19 Spread By 2027

06-21-2021 04:38 AM CET | Health & Medicine

Press release from: The Insight Partners

Rare Neurological Disease Treatment Market

Rare Neurological Disease Treatment Market

The rare neurological disease treatment market is expected to reach US$13,830.96 Mn in 2027 from US$ 7,300.12Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2020-2027.

Neurological diseases having less diagnostics and treatment options affecting small number of population is termed as rare neurological diseases. These diseases target the nervous system, which include the brain, spinal cord, and all the nerves that run throughout the human body. Amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, Huntington's disease are few examples of rare neurological conditions. The global rare neurological disease treatment market is driven by factors such as rising prevalence of rare neurological diseases and favorable pipeline drugs and robust research activities for the treatment of rare neurological diseases. However, high treatment cost for rare neurological diseases are likely to show negative impact on market growth during the forecast period.

Request for Sample PDF Report at: https://www.theinsightpartners.com/sample/TIPRE00008485/?source=openpr-10425

Major Players in This Report Include:

Allergan plc
Bayer AG
GlaxoSmithKline plc
Johnson & Johnson Services Inc
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd
Takeda Pharmaceutical

Global Rare Neurological Disease Treatment Market– By Indication

Narcolepsy
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
Multiple Sclerosis
Spinal Muscular Atrophy (SMA)
Duchenne Muscular Dystrophy
Other Indications

Global Rare Neurological Disease Treatment Market– By Drug Type

Organic Compounds
Biologics

Global Rare Neurological Disease Treatment Market– By Distribution Channel

Online Pharmacies
Hospital Pharmacies
Retail Pharmacies

In the world of medicine, rare neurological diseases represent significant burden on health systems in terms of disease diagnosis, treatment, and management. Some of the majorly observed rare neurological diseases comprises narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. According to a data published by National Institutes of Neurological Disorders and Stroke in 2019, 7,000 rare neurological diseases have been registered in the US. Additionally, according to the same study, these conditions are responsible for significant number of morbidity and mortality.

Report Highlights:

• Comprehensive overview of parent market & substitute market
• Changing market dynamics in the industry (COVID & Economic Impact Analysis)
• In-depth market segmentation (Trends, Growth with Historical & Forecast Analysis)
• Recent industry trends and development activity
• Competitive landscape (Heat Map Analysis for Emerging Players & Market Share Analysis for Major Players along with detailed Profiles)

Buy this Report Research @ https://www.theinsightpartners.com/buy/TIPRE00008485/?source=openpr-10425

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rare Neurological Disease Treatment Market 2021 Demands to Boost Industry Growth and Revenue Post Covid-19 Spread By 2027 here

News-ID: 2309260 • Views:

More Releases from The Insight Partners

Future of Clean Energy - Complete Guide (PDF)
Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus on Opportunities, Development Strategy, Future Plans, Competitive Landscape and Trends by Forecast to 2031
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape and Industry Poised for Rapid Growth in Future 2031
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and
Nutraceuticals - An Ultimate PDF Guide
Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional

All 5 Releases


More Releases for Neurological

Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth
Neurological Biomarkers Market : An Overview
Introduction: Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for
Neurological Biomarkers Market: An Overview
Introduction: Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of